The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Prilactone Next 10 mg chewable tablets for dogs

Ceva Santé AnimaleVPA10815/035/001

Main Information

Trade NamePrilactone Next 10 mg chewable tablets for dogs
Active SubstancesSpironolactone
Dosage FormChewable tablet
Licence HolderCeva Santé Animale
Licence NumberVPA10815/035/001

Group Information

ATC CodeQC03DA01 spironolactone
Therapeutic ClassNeurological Preparations


License statusAuthorised
Licence Issued22/04/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back